ATE397008T1 - Verfahren zur herstellung von delta 9,11 und 21- chloro corticosteroiden - Google Patents

Verfahren zur herstellung von delta 9,11 und 21- chloro corticosteroiden

Info

Publication number
ATE397008T1
ATE397008T1 AT99108236T AT99108236T ATE397008T1 AT E397008 T1 ATE397008 T1 AT E397008T1 AT 99108236 T AT99108236 T AT 99108236T AT 99108236 T AT99108236 T AT 99108236T AT E397008 T1 ATE397008 T1 AT E397008T1
Authority
AT
Austria
Prior art keywords
steroids
delta
chloro
chlorocorticosteroids
beta
Prior art date
Application number
AT99108236T
Other languages
English (en)
Inventor
Xiaoyong Fu
Tiruvettipuram K Thiruvengadam
Chou-Hong Tann
Junning Lee
Cesar Colon
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE397008T1 publication Critical patent/ATE397008T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99108236T 1994-06-01 1995-05-30 Verfahren zur herstellung von delta 9,11 und 21- chloro corticosteroiden ATE397008T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/252,302 US5502222A (en) 1994-06-01 1994-06-01 Process for preparing delta 9,11 and 21-chloro corticosteroids

Publications (1)

Publication Number Publication Date
ATE397008T1 true ATE397008T1 (de) 2008-06-15

Family

ID=22955451

Family Applications (3)

Application Number Title Priority Date Filing Date
AT99108236T ATE397008T1 (de) 1994-06-01 1995-05-30 Verfahren zur herstellung von delta 9,11 und 21- chloro corticosteroiden
AT95920650T ATE188481T1 (de) 1994-06-01 1995-05-30 Verfahren zur herstellung von delta-9,11 und 21- chloro-steroid-verbindungen
AT99108237T ATE395353T1 (de) 1994-06-01 1995-05-30 Verfahren zur herstellung von delta 9,11 und 21- chloro corticosteroiden

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT95920650T ATE188481T1 (de) 1994-06-01 1995-05-30 Verfahren zur herstellung von delta-9,11 und 21- chloro-steroid-verbindungen
AT99108237T ATE395353T1 (de) 1994-06-01 1995-05-30 Verfahren zur herstellung von delta 9,11 und 21- chloro corticosteroiden

Country Status (18)

Country Link
US (3) US5502222A (de)
EP (3) EP0763054B1 (de)
JP (1) JP2831472B2 (de)
KR (4) KR100226568B1 (de)
AT (3) ATE397008T1 (de)
AU (1) AU696425B2 (de)
CA (1) CA2191324C (de)
DE (3) DE69514352T2 (de)
DK (1) DK0063054T3 (de)
ES (3) ES2306488T3 (de)
FI (3) FI118801B (de)
GR (1) GR3032714T3 (de)
HU (3) HU227379B1 (de)
IL (5) IL113918A (de)
MX (1) MX9605893A (de)
NZ (1) NZ287348A (de)
PT (1) PT763054E (de)
WO (1) WO1995032989A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5502222A (en) * 1994-06-01 1996-03-26 Schering Corporation Process for preparing delta 9,11 and 21-chloro corticosteroids
US5981744A (en) 1995-12-11 1999-11-09 G. D. Searle And Co. Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
PT944644E (pt) 1996-12-11 2003-02-28 Searle & Co Processos para a preparacao de esteroides 9,11-epoxi e intermediarios uteis para esse efeito
US6887991B1 (en) * 1996-12-11 2005-05-03 G. D. Searle & Company Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
AU2003220251A1 (en) * 2002-03-22 2003-10-13 Pharmacia Corporation C-17 spirolactonization and 6,7 oxidation of steroids
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
US7700603B2 (en) 2003-12-15 2010-04-20 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7592348B2 (en) 2003-12-15 2009-09-22 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
JP2010512389A (ja) 2006-12-12 2010-04-22 シェーリング コーポレイション アスパルチルプロテアーゼ阻害剤
EP3656385A1 (de) 2008-05-28 2020-05-27 ReveraGen BioPharma, Inc. Nichthormonale steroide modulatoren von nf-kb zur behandlung von erkrankungen
EP2556083A4 (de) 2010-04-05 2013-12-04 Validus Biopharma Inc Nichthormonale steroide modulatoren von nf-kappa-b zur krankheitsbehandlung
CN102225959B (zh) * 2011-04-29 2012-11-07 中国科学院上海有机化学研究所 一种16β-甲基-17α-羟基孕甾-3,20-二酮化合物及其合成方法
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
CN107840865A (zh) * 2016-09-20 2018-03-27 天津金耀集团有限公司 一种甲泼尼龙的制备方法
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions
US10953257B2 (en) 2019-04-19 2021-03-23 Kidde Technologies, Inc. Fire suppression composition
US11326998B2 (en) 2019-04-19 2022-05-10 Kidde Technologies, Inc. System and method for monitoring a fire suppression blend
EP4134373A1 (de) * 2021-08-12 2023-02-15 Santhera Pharmaceuticals (Schweiz) AG Synthese von delta-9,11-steroiden

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE28369E (en) * 1957-02-27 1975-03-18 Atcc-zxs
US3947409A (en) * 1958-06-19 1976-03-30 Merck & Co., Inc. 16-Alkyl-1,4,9(11)-pregnatrienes and 9,11-epoxides thereof
DE1127895B (de) * 1958-12-24 1962-04-19 Ciba Geigy Verfahren zur Herstellung von reinen 9 (11)-ungesaettigten Steroiden
US3284477A (en) * 1963-07-10 1966-11-08 Schering Corp Diuretic 1, 4, 9(11)-pregnatrienes
US3639434A (en) * 1967-02-02 1972-02-01 Boots Pure Drug Co Ltd 17-acyloxysteroids and their manufacture
US3933799A (en) * 1969-01-29 1976-01-20 Glaxo Laboratories Limited 11β-Halo-9,12-unsubstituted-C19 -steroids
GB1504133A (en) * 1975-02-24 1978-03-15 Palladino G 2-bromo-6beta-fluoro-pregnane compounds
GB1504134A (en) * 1975-02-25 1978-03-15 Palladino G 2-bromo-6beta-fluoro-pregnane compounds
DE2967070D1 (en) * 1978-01-25 1984-08-02 Schering Ag 11,17-substituted pregnanes, their preparation and application for the preparation of pharmaceutical compositions
US4261984A (en) * 1978-04-05 1981-04-14 Syntex (U.S.A.) Inc. 17β-thiocarboxylic acid esters of 3-oxo-4-halo-16β-methylandrost-4-enes
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
DE3640709A1 (de) * 1986-11-28 1988-06-09 Schering Ag Verfahren zur herstellung von 6(alpha),9(alpha)-difluor-11ss,17(alpha)-dihydroxy-16(alpha)-methyl-4-pregnen-3,20-dion und dessen derivate
US4920216A (en) * 1987-05-28 1990-04-24 The Trustees Of Columbia In The City Of New York Selective chlorination of steroids and other substrates directed by covalently linked pyridine derivatives acting as templates
US5502222A (en) * 1994-06-01 1996-03-26 Schering Corporation Process for preparing delta 9,11 and 21-chloro corticosteroids

Also Published As

Publication number Publication date
ATE395353T1 (de) 2008-05-15
DE69535756D1 (de) 2008-06-26
GR3032714T3 (en) 2000-06-30
IL113918A0 (en) 1995-08-31
EP0763054B1 (de) 2000-01-05
KR100290225B1 (ko) 2001-05-15
FI118801B (fi) 2008-03-31
US5750745A (en) 1998-05-12
EP0969012A3 (de) 2004-10-06
WO1995032989A1 (en) 1995-12-07
NZ287348A (en) 1998-12-23
AU696425B2 (en) 1998-09-10
ATE188481T1 (de) 2000-01-15
JP2831472B2 (ja) 1998-12-02
HU1000527D0 (en) 2010-11-29
CA2191324C (en) 2001-08-28
KR100290226B1 (ko) 2001-05-15
DE69514352T2 (de) 2000-08-24
FI20050180L (fi) 2005-02-16
US5502222A (en) 1996-03-26
DK0063054T3 (da) 2000-06-19
FI964739A0 (fi) 1996-11-28
EP0969012B1 (de) 2008-05-14
EP0969011B1 (de) 2008-05-28
US5616742A (en) 1997-04-01
HUT75518A (en) 1997-05-28
PT763054E (pt) 2000-06-30
IL126598A (en) 2003-07-31
FI20050181L (fi) 2005-02-16
FI117599B (fi) 2006-12-15
DE69535765D1 (de) 2008-07-10
ES2306487T3 (es) 2008-11-01
KR100226568B1 (ko) 1999-10-15
DE69514352D1 (de) 2000-02-10
IL126597A (en) 2003-09-17
IL126597A0 (en) 1999-08-17
FI964739L (fi) 1996-11-28
HU227378B1 (en) 2011-05-30
MX9605893A (es) 1997-12-31
ES2140678T3 (es) 2000-03-01
HU0302654D0 (en) 2003-10-28
IL113918A (en) 1999-12-31
IL126598A0 (en) 1999-08-17
CA2191324A1 (en) 1995-12-07
HU227380B1 (en) 2011-05-30
AU2603595A (en) 1995-12-21
JPH09506113A (ja) 1997-06-17
KR100290227B1 (ko) 2001-05-15
ES2306488T3 (es) 2008-11-01
HU227379B1 (en) 2011-05-30
EP0969012A2 (de) 2000-01-05
EP0969011A3 (de) 2004-10-06
FI117600B (fi) 2006-12-15
HU9603299D0 (en) 1997-01-28
EP0969011A2 (de) 2000-01-05
EP0763054A1 (de) 1997-03-19

Similar Documents

Publication Publication Date Title
ATE395353T1 (de) Verfahren zur herstellung von delta 9,11 und 21- chloro corticosteroiden
DE69718942D1 (de) Verfahren zur herstellung von erythromicin a-oxim
DE3777668D1 (de) Schmelzgesponnene kohlenstoffasern von hoher festigkeit und verfahren zu deren herstellung.
DE3778466D1 (de) Modifizierte keramische strukturen und verfahren zu deren herstellung.
ES2097103T1 (es) Metodo de producir almidon cationico.
DE59102866D1 (de) Verfahren zur herstellung von plattenförmigen körpern aus einer mischung von gips und faserstoff sowie anlage zur durchführung dieses verfahrens.
ATA250884A (de) Verfahren zur herstellung von calciumcarbid sowie schachtofen zur durchfuehrung des verfahrens
ATE44532T1 (de) Verfahren zur herstellung von pregnan-derivaten.
ATE150438T1 (de) Verfahren zur herstellung von 1,1,1,2- tetrafluorethan
ES532031A0 (es) Procedimiento de preparacion de 21-hidroxi-20-ceto-delta 16-esteroides y nuevos compuestos intermedios formados en este procedimiento
DE59008362D1 (de) Verfahren zur herstellung von progesteron-derivaten.
ATE121746T1 (de) Verfahren zur herstellung bissilylierter 3- iodmethylcephalosporinderivaten.
ATA85184A (de) Verfahren zur festigkeitssteigerung von einwandigen rohrfoermigen bauteilen, sowie vorrichtung zur durchfuehrung dieses verfahrens
DE3577314D1 (de) Verfahren zur herstellung von 2-beta-d-ribofuranosylselenazol-4-carboxamid.
HUP9700545A2 (hu) (2,3-Dihidro-5-benzofuranil)-acetonitril, eljárás előállítására és alkalmazása ecetsavszármazék előállítására
ATE3983T1 (de) Verfahren zur herstellung von 3,20-dioxo-pregn-4- en und/oder 3,20-dioxo-pregna-1,4-dien.
PFUFF Representation of cracks by dislocations and its application to the fracture toughness of metals
FZ Software of power series solution for non-linear free oscillations
WO1988001276A3 (fr) PROCEDE DE PRODUCTION DE STEROIDES DE (Z)-17alpha-VINYLE HALOGENE
ES8507155A3 (es) Metodo para la obtencion de esteroides de la serie de prednisolona

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties